• 1
    Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of CD. Aliment Pharmacol Ther 1994; 8: 3543.
  • 2
    Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology 1995; 108: 3459.
  • 3
    McLeod RS, Wolff BG, Steinhart H, et al. Prophylactic mesalazine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995; 109: 40413.
  • 4
    Florent C, Cortot A, Quandale P, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Eur J Gastroenterol Hepatol 1996; 8: 22933.
  • 5
    Sutherland LR, Martin F, Bailey RJ, et al. A randomized, placebo-controlled, double-blind trial of mesalazine in the maintenance of remission of Crohn's disease. Gastroenterology 1997; 112: 106977.
  • 6
    Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalazine. European Cooperative Crohn's Disease Study VI. Gastroenterology 2000; 118: 26473.
  • 7
    Cammà C, Giunta M, Rosselli M, Cottone M. 5-aminosalicylic acid in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997; 113: 146573.
  • 8
    Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 161721.
  • 9
    Rutgeerts P, Assche GV, D'Haens G, et al. Ornidazol for prophylaxis of post-operative Crohn's disease: final results of a double blind placebo controlled trial. Gastroenterology 2002; 122: A80(Abstract).
  • 10
    Korelitz B, Hanauer S, Rutgeerts P, Present D, Peppercorn M. Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: a 2 year multicenter trial. Gastroenterology 1998; 114: A1011(Abstract).
  • 11
    Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999; 116: 294300.
  • 12
    Ewe K, Bottger T, Burh HJ, Ecker KW, Otto HF. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomised placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999; 11: 27782.
  • 13
    Papi C, Lucchetti R, Gili L, Montanti S, Koch M, Capurso L. Budesonide in the treatment of Crohn's disease: a meta-analysis. Aliment Pharmacol Ther 2000; 14: 141928.
  • 14
    Colombel JF, Rutgeerts P, Malchow H, et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 2001; 49: 426.
  • 15
    Cottone M, Cammà C. Mesalamine and relapse prevention in Crohn's disease. Gastroenterology 2000; 118: 597.
  • 16
    Cottone M, Cammà C. Reply to: Mesalamine maintenance therapy for Crohn's disease. Gastroenterology 2001; 120: 5856.
  • 17
    Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99: 95663.
  • 18
    Sandborn WJ, Feagan BJ, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122: 51230.
  • 19
    Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 43944.
  • 20
    Cammà C, Viscido A, Latella G, Caprilli R, Cottone M. Mesalamine in the prevention of clinical and endoscopic postoperative recurrence of Crohn's disease: a meta-analysis. Digest Liver Dis 2002; 34: A86(Abstract).
  • 21
    D'Haens G, Rutgeerts P. Postoperative recurrence of Crohn's disease: pathophysiology and prevention. Inflam Bowel Dis 1999; 5: 295303.